Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 77

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 77
---
 shares of Enfusion Common Stock held in your account and you will receive instructions from your bank, brokerage firm or other nominee describing how to vote your shares of Enfusion Common Stock. The availability of Internet or telephonic voting will depend on the nominee’s voting process. Please check with your bank, brokerage firm or other nominee and follow the voting procedures your bank, brokerage firm or other nominee provides. If you are a beneficial owner and do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Enfusion Common Stock with respect to “non-routine”matters, a broker “non-vote”occurs with respect to those matters. Under applicable stock exchange rules, the organization that holds your shares of Enfusion Common Stock (i.e., your bank, brokerage firm or other nominee) may generally vote on routine matters at its discretion but cannot vote your shares on “non-routine”matters without your instructions. If you are a beneficial owner and the organization that holds your shares of Enfusion Common Stock does not receive instructions from you on how to vote your shares of Enfusion Common Stock on a non-routinematter, the organization that holds your shares of Enfusion Common Stock will inform the inspector of elections that it does not have the authority to vote your shares on such matters. The Merger Agreement Proposal and the Adjournment Proposal will be considered “non-routine.”Accordingly, if you are a beneficial owner and do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Enfusion Common Stock, your bank, brokerage firm or other nominee generally will not be permitted to vote your shares on any of the proposals. If you are a beneficial holder, Enfusion strongly encourages you to provide voting instructions to your bank, brokerage firm or other nominee so that your vote will be counted on all matters. If you are a beneficial owner, you are invited to participate in the Special Meeting; however, you may not vote your shares at the Special Meeting unless you obtain a legal proxy from your bank, brokerage firm or other nominee that holds your shares, giving you the right to vote the shares at the Special Meeting. Revocation of Proxies Enfusion Stockholders of record may revoke their proxies at any time prior to the voting at the Special Meeting in any of the following ways:

| • |     | signing and delivering a new proxy relating to the same shares and bearing a later date than the original proxy; |

| • |     | sending a signed, written notice